News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
639,560 Results
Type
Article (49881)
Company Profile (399)
Press Release (589280)
Multimedia
Podcasts (98)
Webinars (12)
Section
Business (168948)
Career Advice (3098)
Deals (31395)
Drug Delivery (110)
Drug Development (80224)
Employer Resources (180)
FDA (15385)
Job Trends (13494)
News (302059)
Policy (29490)
Tag
Academia (2806)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (90)
Alliances (45079)
ALS (96)
Alzheimer's disease (1440)
Antibody-drug conjugate (ADC) (146)
Approvals (15356)
Artificial intelligence (269)
Autoimmune disease (27)
Automation (14)
Bankruptcy (302)
Best Places to Work (11045)
BIOSECURE Act (19)
Biosimilars (102)
Biotechnology (308)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (292)
Cancer (2344)
Cardiovascular disease (190)
Career advice (2615)
Career pathing (33)
CAR-T (173)
Cell therapy (482)
Cervical cancer (20)
Clinical research (65075)
Collaboration (870)
Company closure (1)
Compensation (504)
Complete response letters (27)
COVID-19 (2625)
CRISPR (47)
C-suite (250)
Cystic fibrosis (106)
Data (2231)
Decentralized trials (2)
Denatured (30)
Depression (52)
Diabetes (284)
Diagnostics (5743)
Digital health (18)
Diversity (7)
Diversity, equity & inclusion (45)
Drug discovery (129)
Drug pricing (112)
Drug shortages (32)
Duchenne muscular dystrophy (101)
Earnings (63194)
Editorial (45)
Employer branding (23)
Employer resources (157)
Events (107104)
Executive appointments (715)
FDA (16641)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (770)
Gene editing (116)
Generative AI (24)
Gene therapy (354)
GLP-1 (776)
Government (4418)
Grass and pollen (6)
Guidances (61)
Healthcare (18589)
Huntington's disease (23)
IgA nephropathy (30)
Immunology and inflammation (138)
Indications (30)
Infectious disease (2764)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (49)
Intellectual property (98)
Interviews (604)
IPO (14877)
IRA (47)
Job creations (2894)
Job search strategy (2142)
Kidney cancer (10)
Labor market (36)
Layoffs (453)
Leadership (23)
Legal (6250)
Liver cancer (72)
Lung cancer (329)
Lymphoma (155)
Machine learning (7)
Management (63)
Manufacturing (320)
MASH (71)
Medical device (12082)
Medtech (12086)
Mergers & acquisitions (17106)
Metabolic disorders (737)
Multiple sclerosis (81)
NASH (21)
Neurodegenerative disease (103)
Neuropsychiatric disorders (33)
Neuroscience (2018)
NextGen: Class of 2025 (6497)
Non-profit (4519)
Now hiring (30)
Obesity (394)
Opinion (266)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (77)
Parkinson's disease (155)
Partnered (20)
Patents (233)
Patient recruitment (112)
Peanut (49)
People (50484)
Pharmaceutical (80)
Pharmacy benefit managers (21)
Phase I (20350)
Phase II (28772)
Phase III (21513)
Pipeline (1210)
Policy (155)
Postmarket research (2383)
Preclinical (8643)
Press Release (67)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (265)
Rare diseases (421)
Real estate (5168)
Recruiting (71)
Regulatory (20967)
Reports (37)
Research institute (2444)
Resumes & cover letters (495)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (79)
Series A (134)
Series B (87)
Service/supplier (9)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3380)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (39)
The Weekly (67)
Vaccines (706)
Venture capitalists (42)
Weight loss (274)
Women's health (33)
Worklife (20)
Date
Today (141)
Last 7 days (894)
Last 30 days (2584)
Last 365 days (32841)
2025 (10755)
2024 (35106)
2023 (39346)
2022 (49733)
2021 (54078)
2020 (51863)
2019 (44912)
2018 (34057)
2017 (31454)
2016 (30916)
2015 (35575)
2014 (27727)
2013 (22622)
2012 (23829)
2011 (24473)
2010 (22175)
Location
Africa (883)
Alabama (54)
Alaska (6)
Arizona (175)
Arkansas (14)
Asia (38132)
Australia (6705)
California (6003)
Canada (1945)
China (538)
Colorado (259)
Connecticut (270)
Delaware (145)
Europe (88894)
Florida (870)
Georgia (209)
Idaho (58)
Illinois (548)
India (26)
Indiana (285)
Iowa (11)
Japan (160)
Kansas (97)
Kentucky (25)
Louisiana (11)
Maine (48)
Maryland (860)
Massachusetts (4665)
Michigan (213)
Minnesota (370)
Mississippi (1)
Missouri (80)
Montana (28)
Nebraska (21)
Nevada (53)
New Hampshire (61)
New Jersey (1691)
New Mexico (29)
New York (1710)
North Carolina (1001)
North Dakota (8)
Northern California (2617)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1343)
Puerto Rico (11)
Rhode Island (32)
South America (1173)
South Carolina (22)
Southern California (2251)
Tennessee (78)
Texas (864)
United States (22724)
Utah (159)
Virginia (145)
Washington D.C. (58)
Washington State (565)
West Virginia (3)
Wisconsin (50)
639,560 Results for "the blackstone group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront
April 4, 2025
·
4 min read
Press Releases
Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion
February 11, 2025
·
7 min read
Business
Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology & Inflammation
Blackstone (NYSE:BX) today announced the launch of the Blackstone Life Sciences (“Blackstone”) portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation.
May 15, 2024
·
5 min read
Press Releases
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
April 30, 2025
·
3 min read
Business
Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Blackstone announced a new collaboration with Moderna, Inc. through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750 million to fund Moderna’s influenza program.
March 27, 2024
·
2 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
Drug Development
Uniquity Bio Emerges from Stealth with $300M from Blackstone, Targets Asthma and COPD
Armed with a $300 million commitment from Blackstone Life Sciences and a former Merck monoclonal antibody, Uniquity Bio is starting Phase II clinical trials in asthma and chronic obstructive pulmonary disease.
May 15, 2024
·
2 min read
·
Kate Goodwin
Press Releases
Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France
April 29, 2025
·
3 min read
1 of 63,956
Next
